Tilak Company Profile

09:26 EDT 20th October 2018 | BioPortfolio

News Articles [3 Associated News Articles listed on BioPortfolio]

Tilak gets CE mark for its first mobile medical game in ophthalmology

Tilak has secured CE mark approval for Odysight, its first mobile medical game dedicated to the monitoring of patients with chronic eye diseases.

Tilak Strengthens Its Governance

A team of medical and regulatory experts working with mobile game professionals to address the next stages of development Tilak, a start-up from the iBionext network developin...

Tilak Announces CE Marking for Odysight, Its First Mobile Medical Game in Ophthalmology

Launching of the Beta-testing phase in France and in the United Kingdom Tilak, a company from the iBionext network developing mobile medical applications for the manage...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "Tilak" on BioPortfolio

We have published hundreds of Tilak news stories on BioPortfolio along with dozens of Tilak Clinical Trials and PubMed Articles about Tilak for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tilak Companies in our database. You can also find out about relevant Tilak Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record